Agilent Technologies Inc vs First Trust Cloud Computing ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while First Trust Cloud Computing ETF trades at $161.1. The key difference: Agilent Technologies Inc pays a 0.69% dividend while First Trust Cloud Computing ETF pays none, and First Trust Cloud Computing ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | SKYY | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | — |
52-Week High | $157.20 | $161.09 |
52-Week Low | $110.24 | $104.16 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
SKYY, trading at $156.17, gained 3.71% today, reflecting strong bullish momentum from moving averages and positive sentiment around cloud computing and AI trends. The ETF's technical indicators show overbought conditions with RSI levels above 76, while support is firm near $155. Recent news highlights SKYY's diversified exposure to cloud infrastructure and AI, benefiting from secular growth in digital transformation.
Outlook remains positive due to AI adoption and cloud migration tailwinds, but risks include overvaluation concerns and competitive pressures. Investors should weigh the strong technical trend against high RSI readings and monitor earnings growth for sustained upside.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →